← Back to Search

PMP Use Mandate Letter for Opioid Use Disorder

N/A
Waitlist Available
Led By David Powell, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Wrote concurrent prescription for opioids and benzodiazepines OR opioids and gabapentinoids
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

This study is evaluating whether a letter to doctors may help reduce the number of patients who are prescribed opioids and benzodiazepines.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Count of Patients with Co-Prescriptions
Rate of Prescribers Checking PMP

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Prescribing Information + PMP Use MandateExperimental Treatment1 Intervention
Group II: Prescribing InformationExperimental Treatment1 Intervention
Group III: PMP Use MandateExperimental Treatment1 Intervention
Group IV: Control / As-UsualActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prescribing Information + PMP Use Mandate Letter
2021
N/A
~12000
Prescribing Information Letter
2021
N/A
~12000
PMP Use Mandate Letter
2021
N/A
~12000

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,449,015 Total Patients Enrolled
University of Southern CaliforniaOTHER
906 Previous Clinical Trials
1,584,288 Total Patients Enrolled
Minnesota Management and Budget AgencyUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Nudging Providers to Curtail Dangerous Opioid Prescribing: A Trial to Investigate Mechanisms
2021. "Nudging Providers to Curtail Dangerous Opioid Prescribing: A Trial to Investigate Mechanisms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04628832.
~3000 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top